Skip to content

Regenxbio RGNX WA — Operating Lease Liability

Similar metrics at other companies

Tarsus Pharmaceuticals, Inc. logo
TARSOperating lease liability
$4.36M+2,788%
1st Source Corporation logo
SRCEOperating lease liability
$3.99M-8.7%
The Vita Coco Company, Inc. logo
COCOLease liability
$3.13M+975%
ADMA Biologics logo
ADMAOperating And Financing Lease Liability
$7.5M-2.6%
Nurix Therapeutics, Inc. logo
NRIXOperating lease liabilities
$15.92M+160%
BGC Group, Inc. logo
BGCLease Liability
$197.04M+41.7%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Regenxbio’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's wa — operating lease liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's WA — operating lease liability?
Regenxbio (RGNX) reported WA — operating lease liability of $2.8M in Q4 2025.
What does WA — operating lease liability mean?
This metric represents the present value of future lease payments for assets utilized by the WA segment, recognized as a financial obligation. It reflects the company's contractual commitment to make payments for the right to use leased property, plant, or equipment over the remaining lease term. Analyzing this liability provides insight into the segment's fixed cost structure and the long-term financial obligations associated with its operational infrastructure.